Antibody tests for identification of current and past infection with SARS‐CoV‐2

T Fox, J Geppert, J Dinnes, K Scandrett… - Cochrane database …, 2022 - cochranelibrary.com
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

Evaluation of seropositivity following BNT162b2 messenger RNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer

A Massarweh, N Eliakim-Raz, A Stemmer… - JAMA …, 2021 - jamanetwork.com
Importance Patients with cancer undergoing treatment are at high risk of COVID-19 following
SARS-CoV-2 infection; however, their ability to produce an adequate antibody response to …

Quick COVID-19 healers sustain anti-SARS-CoV-2 antibody production

Y Chen, A Zuiani, S Fischinger, J Mullur, C Atyeo… - Cell, 2020 - cell.com
Antibodies are key immune effectors that confer protection against pathogenic threats. The
nature and longevity of the antibody response to SARS-CoV-2 infection are not well defined …

Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19

Z Meng, S Guo, Y Zhou, M Li, M Wang… - Signal transduction and …, 2021 - nature.com
The worldwide pandemic of coronavirus disease 2019 (COVID-19) presents us with a
serious public health crisis. To combat the virus and slow its spread, wider testing is …

Poor anti-SARS-CoV-2 humoral and T-cell responses after 2 injections of mRNA vaccine in kidney transplant recipients treated with belatacept

N Chavarot, A Ouedrani, O Marion… - …, 2021 - journals.lww.com
AO, JZ, LC, NC, NK, AS, and FL participated in research design. AO, AS, FA, CC, JI, ML-. V.,
NC, and NK participated in data analysis. AO, AS, CL, LC, ML-. V., NC, and NK participated …

[HTML][HTML] Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept

N Chavarot, A Morel, M Leruez-Ville, E Vilain… - American Journal of …, 2021 - Elsevier
Poor responses to mRNA COVID-19 vaccine have been reported after 2 vaccine injections
in kidney transplant recipients (KTRs) treated with belatacept. We analyzed the humoral …

SARS-CoV-2 in first trimester pregnancy: a cohort study

N la Cour Freiesleben, P Egerup, KVR Hviid… - Human …, 2021 - academic.oup.com
STUDY QUESTION Does maternal infection with severe acute respiratory syndrome
Coronavirus-2 (SARS-CoV-2) in first trimester pregnancy have an impact on the fetal …

Cellular and humoral immune response after mRNA‐1273 SARS‐CoV‐2 vaccine in liver and heart transplant recipients

S Herrera, J Colmenero, M Pascal… - American Journal of …, 2021 - Wiley Online Library
Recently published studies have found an impaired immune response after SARS‐CoV‐2
vaccination in solid organ recipients. However, most of these studies have not assessed …

Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents

N Koerber, A Priller, S Yazici, T Bauer… - Nature …, 2022 - nature.com
Anti-viral immunity continuously declines over time after SARS-CoV-2 infection. Here, we
characterize the dynamics of anti-viral immunity during long-term follow-up and after …

Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study

C Erikstrup, AD Laksafoss, J Gladov… - The Lancet Regional …, 2022 - thelancet.com
Summary Background Introduction of the Omicron variant caused a steep rise in SARS-CoV-
2 infections despite high vaccination coverage in the Danish population. We used blood …